Seattle, WA, United States of America

Nikolaus Sebastian Trede

This inventor holds 1 USPTO granted patent and 6 published patent applications and 3 EPO patents. Top assignee: Juno Therapeutics Gmbh. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nikolaus Sebastian Trede. Retrieved from https://idiyas.com/inventor/nikolaus-sebastian-trede

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 25.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: **The Innovations of Nikolaus Sebastian Trede in CAR T-Cell Therapy**

Introduction

Nikolaus Sebastian Trede is an innovative inventor based in Seattle, WA, recognized for his contributions to the field of cell therapy. With a focus on enhancing the safety and efficacy of therapeutic T cell compositions, his work aims to address significant challenges in the treatment of various diseases, particularly through CAR T-cell therapy.

Latest Patents

Trede holds a patent titled "Determining toxicity risk in CAR T-cell therapy," which details methods, compositions, and articles of manufacture for use in cell therapy. This patent provides crucial advancements by allowing for the administration of therapeutic T cell compositions while mitigating toxicity risks. The methods outlined involve cells that express recombinant receptors like chimeric antigen receptors (CARs) or other transgenic receptors such as T cell receptors (TCRs). His innovative approaches enhance the effectiveness of treatments and offer potential solutions for safer patient care.

Career Highlights

Currently, Nikolaus Trede is employed at Juno Therapeutics GmbH, where he continues to push the boundaries of research and development in immunotherapies. His singular patent reflects a commitment to scientific advancement, with implications that could revolutionize treatment protocols in oncology and beyond.

Collaborations

Trede has collaborated with notable colleagues, including Brian Christin and Michael Gerard Covington. Together, they contribute to a collaborative environment that fosters innovation and growth within the therapeutic landscape. Their combined expertise enhances the robustness of the research conducted at Juno Therapeutics.

Conclusion

Nikolaus Sebastian Trede's work signifies a vital step forward in CAR T-cell therapy, showcasing the importance of innovation in improving treatment outcomes. Through his patent and collaborative efforts, he continues to inspire advancements that may considerably impact patient care and revolutionize the therapeutic landscape. His dedication and ingenuity exemplify the pivotal role of inventors in modern medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…